Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7785)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hou W, Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy. World J Gastroenterol 2013; 19(44): 7836-7845 [PMID: 24307777 DOI: 10.3748/wjg.v19.i44.7836] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i44/7836.htm |
| Number | Citing Articles |
| 1 |
Marie-Laure Plissonnier, Katharina Herzog, Massimo Levrero, Mirjam B. Zeisel. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma. Viruses 2018; 10(11): 591 doi: 10.3390/v10110591
|
| 2 |
Keigo Machida. HCV and tumor-initiating stem-like cells. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.903302
|
| 3 |
Ashraf Mohamadkhani. Long Noncoding RNAs in Interaction With RNA Binding Proteins in Hepatocellular Carcinoma. Hepatitis Monthly 2014; 14(5) doi: 10.5812/hepatmon.18794
|
| 4 |
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. International Journal of Molecular Sciences 2019; 20(6): 1358 doi: 10.3390/ijms20061358
|
| 5 |
Bo Guo, Shengzhe Yan, Lei Zhai, Yanzhen Cheng. LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA. Cytotechnology 2024; 76(2): 259 doi: 10.1007/s10616-023-00614-x
|
| 6 |
Pei Min, Wenshuai Li, Deqing Zeng, Yanyun Ma, Diannan Xu, Wanwei Zheng, Feng Tang, Jian Chen, Jianping Shi, Heping Hu, Jiucun Wang, Dongqin Yang, Jie Liu, Jun Zhang, Mingqing Zhang. A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6. Bulletin du Cancer 2017; 104(4): 311 doi: 10.1016/j.bulcan.2016.11.021
|
| 7 |
Zhen Jiang, Haichao Liu. Metformin inhibits tumorigenesis in HBV‐induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX. Journal of Cellular Biochemistry 2018; 119(6): 4482 doi: 10.1002/jcb.26555
|
| 8 |
Nithya Krishnamurthy, Emily Spencer, Ali Torkamani, Laura Nicholson. Liquid Biopsies for Cancer: Coming to a Patient near You. Journal of Clinical Medicine 2017; 6(1): 3 doi: 10.3390/jcm6010003
|
| 9 |
Abdullah Ahmed Gibriel, Manal Fouad Ismail, Hameis Sleem, Naglaa Zayed, Ayman Yosry, Saeed M. El-Nahaas, Nagwa Ibrahim Shehata. Diagnosis and staging of HCV associated fibrosis, cirrhosis and hepatocellular carcinoma with target identification for miR-650, 552-3p, 676-3p, 512-5p and 147b. Cancer Biomarkers 2022; 34(3): 413 doi: 10.3233/CBM-210456
|
| 10 |
Miguel E. Quiñones-Mateu, Santiago Avila, Gustavo Reyes-Teran, Miguel A. Martinez. Deep sequencing: Becoming a critical tool in clinical virology. Journal of Clinical Virology 2014; 61(1): 9 doi: 10.1016/j.jcv.2014.06.013
|
| 11 |
YULIN XIONG, MING JIA, JING YUAN, CHANGJIANG ZHANG, YAN ZHU, XUEMEI KUANG, LIN LAN, XIAOHONG WANG. STAT3-regulated long non-coding RNAs lnc-7SK and lnc-IGF2-AS promote hepatitis C virus replication. Molecular Medicine Reports 2015; 12(5): 6738 doi: 10.3892/mmr.2015.4278
|
| 12 |
Kaveri Sidhu, Neetu Rohit Kapoor, Vijaya Pandey, Vijay Kumar. The “Macro” World of microRNAs in Hepatocellular Carcinoma. Frontiers in Oncology 2015; 5 doi: 10.3389/fonc.2015.00068
|
| 13 |
Sara R. Selitsky, Jeanette Baran-Gale, Masao Honda, Daisuke Yamane, Takahiro Masaki, Emily E. Fannin, Bernadette Guerra, Takayoshi Shirasaki, Tetsuro Shimakami, Shuichi Kaneko, Robert E. Lanford, Stanley M. Lemon, Praveen Sethupathy. Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C. Scientific Reports 2015; 5(1) doi: 10.1038/srep07675
|
| 14 |
Sharad Khare, Tripti Khare, Raghu Ramanathan, Jamal A. Ibdah. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022; 12(5): 645 doi: 10.3390/biom12050645
|
| 15 |
Ricardo Parreira, Lee W. Riley, Ronald E. Blanton. Laboratory Methods in Molecular Epidemiology: Viral Infections. Microbiology Spectrum 2018; 6(6) doi: 10.1128/microbiolspec.AME-0003-2018
|
| 16 |
Yulin Xiong, Jing Yuan, Changjiang Zhang, Yan Zhu, Xuemei Kuang, Lin Lan, Xiaohong Wang. The STAT3-regulated long non-coding RNA Lethe promote the HCV replication. Biomedicine & Pharmacotherapy 2015; 72: 165 doi: 10.1016/j.biopha.2015.04.019
|
| 17 |
Chao-Hung Hung, Yi-Chun Chiu, Chien-Hung Chen, Tsung-Hui Hu. MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/486407
|
| 18 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_168-1
|
| 19 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3029 doi: 10.1007/978-3-319-26956-6_168
|
| 20 |
Mirjam B. Zeisel, Francesca Guerrieri, Massimo Levrero. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. Journal of Clinical Medicine 2021; 10(8): 1715 doi: 10.3390/jcm10081715
|
| 21 |
Abdullahi Dandare, Muhammad Jawad Khan, Aisha Naeem, Afrose Liaquat. Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. Genes & Diseases 2023; 10(6): 2393 doi: 10.1016/j.gendis.2022.05.022
|
| 22 |
Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jilkova, Samia Afzal. Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers 2023; 3(1): 82 doi: 10.3390/livers3010008
|
| 23 |
Chit Tam, Jack Ho Wong, Stephen Kwok Wing Tsui, Tao Zuo, Ting Fung Chan, Tzi Bun Ng. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Applied Microbiology and Biotechnology 2019; 103(12): 4649 doi: 10.1007/s00253-019-09837-5
|
| 24 |
Ragunath Singaravelu, Rodney S Russell, D Lorne Tyrrell, John Paul Pezacki. Hepatitis C virus and microRNAs: miRed in a host of possibilities. Current Opinion in Virology 2014; 7: 1 doi: 10.1016/j.coviro.2014.03.004
|
| 25 |
Elodie Miquelestorena‐Standley, Anne Tallet, Christine Collin, Eric Piver, Anne De Muret, Ephrem Salamé, Pascal Bourlier, Thibault Kervarrec, Serge Guyétant, Jean‐Christophe Pagès. Interest of variations in microRNA‐152 and ‐122 in a series of hepatocellular carcinomas related to hepatitis C virus infection. Hepatology Research 2018; 48(7): 566 doi: 10.1111/hepr.12915
|
| 26 |
Zhi-qin Li, Xin-yu Gu, Jin-xing Hu, Yu Ping, Hua Li, Jing-ya Yan, Juan Li, Ran Sun, Zu-jing Yu, Yi Zhang. Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling. Bioscience Reports 2016; 36(3) doi: 10.1042/BSR20160088
|
| 27 |
Rong Ma, Palsamy Periyasamy, Raghubendra Singh Dagur, Susmita Sil, Zhongbin Wang, Shilpa Buch, Guoku Hu. HIV-Associated Neurocognitive Disorders. 2024; : 487 doi: 10.1016/B978-0-323-99744-7.00005-5
|